Chemical Compound
9-[(1S,3R,4S)-4-Dimethylphenylsilyl-3-(benzyloxymethyl)-2-methylenecyclopentyl]guanine; 6H-Purin-6-one, 2-amino-9-[(1S,3R,4S)-4-(dimethylphenylsilyl)-2-methylene-3-[(phenylmethoxy)methyl]cyclopentyl]-1,9-dihydro-; 2-Amino-9-[(1S,3R,4S)-3-[(benzyloxy)methyl]-4-[dimethyl(phenyl)silyl]-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one; Entecavir Monohydrate Imp. F (EP)
CAS Registry Number
649761-24-0
Primary record
9-[(1S,3R,4S)-4-Dimethylphenylsilyl-3-(benzyloxymethyl)-2-methylenecyclopentyl]guanine; 6H-Purin-6-one, 2-amino-9-[(1S,3R,4S)-4-(dimethylphenylsilyl)-2-methylene-3-[(phenylmethoxy)methyl]cyclopentyl]-1,9-dihydro-; 2-Amino-9-[(1S,3R,4S)-3-[(benzyloxy)methyl]-4-[dimethyl(phenyl)silyl]-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one; Entecavir Monohydrate Imp. F (EP)
- 库存
- 3,073 克
- 纯度
- 99.3 %
- CAS
- 649761-24-0
化合物标识与属性
- CAS
- 649761-24-0
- PubChem CID
- 136096441
- SMILES
- C[Si](C)([C@H]1C[C@@H](C(=C)[C@@H]1COCC2=CC=CC=C2)N3C=NC4=C3N=C(NC4=O)N)C5=CC=CC=C5
- Canonical SMILES
- C=C1[C@H](COCc2ccccc2)[C@@H]([Si](C)(C)c2ccccc2)C[C@@H]1n1cnc2c(=O)[nH]c(N)nc21
名称与同义词
- Entecavir EP Impurity F
- Entecavir impurities F
- LTP7YND4GS
- Entecavir Related Compound A
- UNII-LTP7YND4GS
- 3-Benzyl-4-silyl entecavir
- Entecavir impurity F CRS
- 649761-24-0
- SCHEMBL12527744
- CTK5C1959
- Entecavir USP Related Compound A
- AMY38911
- 6-O-Benzyl-4-dehydroxy-4-diMethylphenylsilyl Entecavir
- ENTECAVIR RELATED COMPOUND A [USP-RS]
- ENTECAVIR MONOHYDRATE IMPURITY F [EP IMPURITY]
- 2-Amino-9-((1S,3R,4S)-3-((benzyloxy)methyl)-4-(dimethyl(phenyl)silyl)-2-methylenecyclopentyl)-1H-purin-6(9H)-one
- 2-Amino-9-[(1S,3R,4S)-4-[dimethyl(phenyl)silyl]-2-methylidene-3-(phenylmethoxymethyl)cyclopentyl]-1H-purin-6-one
- 2-AMINO-9-{(1S,3R,4S)-3-[(BENZYLOXY)METHYL]-4-[DIMETHYL(PHENYL)SILYL]-2-METHYLIDENECYCLOPENTYL}-9H-PURIN-6(1H)-ONE
- 9-((1S,3R,4S)-4-Dimethylphenylsilyl-3-(benzyloxymethyl)-2-methylenecyclopentyl)guanine
- 2-amino-9-((1S,3R,4S)-3-((benzyloxy)methyl)-4-(dimethyl(phenyl)silyl)-2-methylenecyclopentyl)-3H-purin-6(9H)-one
- 2-Amino-9-((1S,3R,4S)-4-(dimethylphenylsilyl)-2-methylene-3-((phenylmethoxy)methyl)cyclopentyl)-1,9-dihydro-6H-purin-6-one
- 2-Amino-9-[(1S,3R,4S)-4-(dimethylphenylsilyl)-2-methylene-3-[(phenylmethoxy)methyl]cyclopentyl]-1,9-dihydro-6H-purin-6-one
- 6H-Purin-6-one, 2-amino-9-((1S,3R,4S)-4-(dimethylphenylsilyl)-2-methylene-3-((phenylmethoxy)methyl)cyclopentyl)-1,9-dihydro-
- 6H-Purin-6-one, 2-amino-9-[(1S,3R,4S)-4-(dimethylphenylsilyl)-2-methylene-3-[(phenylmethoxy)methyl]cyclopentyl]-1,9-dihydro-
- 9-[(1S,3R,4S)-4-Dimethylphenylsilyl-3-(benzyloxymethyl)-2-methylenecyclopentyl]guanine; 6H-Purin-6-one, 2-amino-9-[(1S,3R,4S)-4-(dimethylphenylsilyl)-2-methylene-3-[(phenylmethoxy)methyl]cyclopentyl]-1,9-dihydro-; 2-Amino-9-[(1S,3R,4S)-3-[(benzyloxy)methyl]-4-[dimethyl(phenyl)silyl]-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one; Entecavir Monohydrate Imp. F (EP)